ABL Bio, Inc.

ABL Bio, Inc. financial statements

ABL Bio, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueKRW 79.35BEODHD
Net income−KRW 37.81BEODHD
Cash and equivalentsKRW 111.98BEODHD

ABL Bio, Inc. financials on 6ix · ABL Bio, Inc. on 6ix